Efficacy of delayed-release dimethyl fumarate vs glatiramer acetate on a novel composite outcome measure of inflammatory disease activity: Post-hoc analysis of the CONFIRM study

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: 1aebfdeac9d0d801cddd05a93abb0ab1c1d4f9c5
First added on: Apr 30, 2026